CDC report delay
The Washington Post says the CDC delayed a report finding COVID-19 vaccines cut ER visits and hospitalizations by roughly half for healthy adults last winter, and that revelation has ignited heavy debate online. (x.com)
A Centers for Disease Control and Prevention report was set to say last winter’s COVID-19 shot cut emergency-room and urgent-care visits in healthy adults by 50% and cut hospitalizations by 55%, but the paper was pulled before publication by acting director Jay Bhattacharya, according to The Washington Post and Reuters. (reuters.com) The report was scheduled for March 19 in the Morbidity and Mortality Weekly Report, the weekly bulletin the agency uses to publish outbreak findings, vaccine studies, and other public-health data. (cdc.gov) (nytimes.com) Bhattacharya said he objected to the study’s method, arguing that it gave an inaccurate picture of the shot’s benefit. Two outlets reporting the dispute said the design was not unusual at all, because the Centers for Disease Control and Prevention has long used the same kind of observational comparison for respiratory-virus vaccine studies. (nytimes.com) (yahoo.com) You can see that method in public on the agency’s own website. A February 2025 Morbidity and Mortality Weekly Report used CDC-funded vaccine-effectiveness networks to estimate how well the 2024–2025 shot worked against emergency visits and hospital stays. (cdc.gov) That earlier paper found a smaller benefit than the delayed one: 33% protection against emergency-department or urgent-care visits for adults overall, and 45% to 46% protection against hospitalization for immunocompetent adults age 65 and older. (cdc.gov) The delayed paper appears to cover a different slice of people and a different stretch of time. The reported numbers were for healthy adults during last winter, not the older and higher-risk groups that the Centers for Disease Control and Prevention has emphasized most in its current guidance. (washingtonpost.com) (cdc.gov) That timing matters because the agency’s 2025–2026 guidance moved COVID-19 vaccination onto shared clinical decision-making for most people ages 6 months to 64 years, while still stressing vaccination for adults age 65 and older and people at high risk for severe disease. (cdc.gov 1) (cdc.gov 2) So the fight online is not only about one unpublished paper. It is also about whether the federal government is slowing or reshaping evidence that could affect how doctors talk to younger, healthier adults about getting another dose before the next winter wave. (usnews.com) (reuters.com) The sharpest unanswered question is simple: if the method was weak, the agency can publish the paper with caveats or release a revised analysis; if the method was standard, holding it back leaves doctors and patients arguing over a result they still cannot inspect line by line. (nytimes.com) (cdc.gov)
